Patient presents with progressive symmetrical ascending weakness, consistent with Guillain-Barre Syndrome (GBS).  Onset of symptoms reported as [Date of onset], initially experiencing [Initial symptoms, e.g., tingling in toes, distal leg weakness].  Progression to [Current symptoms, e.g., proximal muscle weakness, difficulty ambulating, dyspnea].  Neurological examination reveals diminished deep tendon reflexes in [Affected limbs].  Cranial nerve involvement noted as [Specify cranial nerve deficits, e.g., facial weakness, dysarthria, dysphagia].  Patient denies recent [Relevant negative history, e.g., fever, trauma, tick bites].  Differential diagnosis includes acute inflammatory demyelinating polyneuropathy (AIDP), Miller Fisher syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and other neuromuscular disorders.  Preliminary diagnosis of Guillain-Barre Syndrome is suspected.  Ordered tests include lumbar puncture for cerebrospinal fluid (CSF) analysis, electromyography (EMG) and nerve conduction studies (NCS) to assess peripheral nerve function, and complete blood count (CBC) to rule out other etiologies.  Patient admitted for monitoring of respiratory function and supportive care.  Treatment plan may include intravenous immunoglobulin (IVIG) or plasma exchange (PLEX), depending on clinical course and test results.  Patient education provided on Guillain-Barre Syndrome prognosis, potential complications, and rehabilitation strategies.  ICD-10 code G61.0, acute inflammatory demyelinating polyneuropathy, is considered pending confirmatory testing.  Continued monitoring and reassessment planned.